Department of Industrial Pharmacy and Pharmaceutics, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt.
J Liposome Res. 2020 Mar;30(1):1-11. doi: 10.1080/08982104.2019.1577256. Epub 2019 Jul 15.
In our study, the potential of bilosomes as novel vesicular carrier for the cutaneous delivery of the sulphone compound, Dapsone, for topical treatment of acne was investigated. The effect of different formulation variables (type and concentration of bile salt, and molar ratio of Span 60:cholesterol) on the properties of DPS-loaded bilosomes was investigated using a full factorial design. Design Expert software was used for data analysis and optimization of DPS-loaded bilosomes. The optimized bilosomes, chosen on the basis of their superior properties giving maximum entrapment, release after different time intervals and RE% with minimum vesicle size. Results showed that the bilosome system prepared using Span 60: Cholesterol (5:1) and containing 0.25 M sodium deoxycholate as the bile salt was found to obey these criteria, with a desirability value of 0.637. Therefore, this system was chosen for further assessment for its morphological properties, zeta potential, thermal analysis using differential scanning calorimetry and X-ray diffractometry. Results revealed that the chosen bilosomes were spherical in shape with no aggregation, and contained DPS in a molecularly dispersed amorphous form. Finally, the capability of the optimized DPS-loaded bilosomes to deliver DPS through rat skin layers will be investigated and compared with that of DPS alcoholic solution. Results showed that the amounts of DPS retained in the skin treated with DPS-loaded bilosomes, and DPS alcoholic solution after 24 h were found to be 170.57 ± 55.12 and 120.24 ± 10.7 µg/mL, respectively, representing about 1.5-fold higher drug retained in the bilosomes-treated skin. Finally, the safety and the tolerability of the prepared bilosomes were assessed using histopathological examination, and revealed that the control untreated skin sections and skin sections treated with DPS-loaded bilosomes showed normal histological structures characterized by absence of defects or inflammation. Such results can be considered a good addition in the field of pharmaceutical drug delivery for effective topical therapy of acne.
在我们的研究中,探讨了双分子层囊泡作为新型囊泡载体,将砜化合物氨苯砜(Dapsone)递送至皮肤,用于治疗痤疮的局部治疗。使用完全析因设计研究了不同制剂变量(胆汁盐的类型和浓度,以及 Span 60:胆固醇的摩尔比)对负载 Dapsone 的双分子层囊泡的性质的影响。使用 Design Expert 软件进行数据分析和优化负载 Dapsone 的双分子层囊泡。选择具有最佳性质的优化双分子层囊泡,其最大包封率、不同时间间隔后的释放率和最小囊泡大小的 RE%。结果表明,使用 Span 60:胆固醇(5:1)制备的双分子层囊泡系统,并含有 0.25 M 脱氧胆酸钠作为胆汁盐,被发现符合这些标准,其理想值为 0.637。因此,选择该系统用于进一步评估其形态特性、ζ电位、使用差示扫描量热法和 X 射线衍射法的热分析。结果表明,所选的双分子层囊泡呈球形,没有聚集,并且以分子分散的无定形形式包含 Dapsone。最后,将研究优化后的负载 Dapsone 的双分子层囊泡通过大鼠皮肤层的输送 Dapsone 的能力,并与 Dapsone 醇溶液进行比较。结果表明,在 24 小时后,用负载 Dapsone 的双分子层囊泡处理的皮肤和 Dapsone 醇溶液中保留的 Dapsone 量分别为 170.57±55.12 和 120.24±10.7μg/mL,代表在双分子层囊泡处理的皮肤中保留的药物约增加 1.5 倍。最后,使用组织病理学检查评估了制备的双分子层囊泡的安全性和耐受性,并发现对照未处理的皮肤切片和用负载 Dapsone 的双分子层囊泡处理的皮肤切片显示出正常的组织结构,其特征是没有缺陷或炎症。这些结果可以被认为是药物传递领域的一个很好的补充,可用于痤疮的有效局部治疗。